These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11872641)

  • 1. Catechol estrogen metabolites and conjugates in different regions of the prostate of Noble rats treated with 4-hydroxyestradiol: implications for estrogen-induced initiation of prostate cancer.
    Cavalieri EL; Devanesan P; Bosland MC; Badawi AF; Rogan EG
    Carcinogenesis; 2002 Feb; 23(2):329-33. PubMed ID: 11872641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent binding of catechol estrogens to glutathione catalyzed by horseradish peroxidase, lactoperoxidase, or rat liver microsomes.
    Cao K; Devanesan PD; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
    Chem Res Toxicol; 1998 Aug; 11(8):917-24. PubMed ID: 9705754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors.
    Cavalieri EL; Kumar S; Todorovic R; Higginbotham S; Badawi AF; Rogan EG
    Chem Res Toxicol; 2001 Aug; 14(8):1041-50. PubMed ID: 11511178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.
    Li KM; Todorovic R; Devanesan P; Higginbotham S; Köfeler H; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
    Carcinogenesis; 2004 Feb; 25(2):289-97. PubMed ID: 14578156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of potential biomarkers of estrogen-initiated cancer in the urine of Syrian golden hamsters treated with 4-hydroxyestradiol.
    Todorovic R; Devanesan P; Higginbotham S; Zhao J; Gross ML; Rogan EG; Cavalieri EL
    Carcinogenesis; 2001 Jun; 22(6):905-11. PubMed ID: 11375897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17 beta-estradiol metabolism by hamster hepatic microsomes: comparison of catechol estrogen O-methylation with catechol estrogen oxidation and glutathione conjugation.
    Butterworth M; Lau SS; Monks TJ
    Chem Res Toxicol; 1996 Jun; 9(4):793-9. PubMed ID: 8831825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol.
    Dawling S; Hachey DL; Roodi N; Parl FF
    Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.
    Zahid M; Kohli E; Saeed M; Rogan E; Cavalieri E
    Chem Res Toxicol; 2006 Jan; 19(1):164-72. PubMed ID: 16411670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
    Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
    Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol estrogens induce proliferation and malignant transformation in prostate epithelial cells.
    Mosli HA; Tolba MF; Al-Abd AM; Abdel-Naim AB
    Toxicol Lett; 2013 Jul; 220(3):247-58. PubMed ID: 23685341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4-hydroxyestradiol: potential biomarkers for estrogen-initiated cancer.
    Devanesan P; Todorovic R; Zhao J; Gross ML; Rogan EG; Cavalieri EL
    Carcinogenesis; 2001 Mar; 22(3):489-97. PubMed ID: 11238191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
    Cavalieri E; Rogan E
    Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
    Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
    Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
    Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
    Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined testosterone and estradiol-17 beta treatment on the metabolism of E2 in the prostate and liver of noble rats.
    Lane KE; Ricci MJ; Ho SM
    Prostate; 1997 Mar; 30(4):256-62. PubMed ID: 9111603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol metabolites of polychlorinated biphenyls inhibit the catechol-O-methyltransferase-mediated metabolism of catechol estrogens.
    Garner CE; Burka LT; Etheridge AE; Matthews HB
    Toxicol Appl Pharmacol; 2000 Jan; 162(2):115-23. PubMed ID: 10637135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
    Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
    Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-acetylcysteine, and glutathione.
    Cao K; Stack DE; Ramanathan R; Gross ML; Rogan EG; Cavalieri EL
    Chem Res Toxicol; 1998 Aug; 11(8):909-16. PubMed ID: 9705753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators.
    Cavalieri EL; Stack DE; Devanesan PD; Todorovic R; Dwivedy I; Higginbotham S; Johansson SL; Patil KD; Gross ML; Gooden JK; Ramanathan R; Cerny RL; Rogan EG
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10937-42. PubMed ID: 9380738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in 4-hydroxyestradiol levels in leukocytes are related to CYP1A1(∗)2C, CYP1B1(∗)3 and COMT Val158Met allelic variants.
    Martínez-Ramírez OC; Pérez-Morales R; Petrosyan P; Castro-Hernández C; Gonsebatt ME; Rubio J
    Steroids; 2015 Oct; 102():1-6. PubMed ID: 26123186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.